Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2025-12-25 @ 1:31 AM
NCT ID:
NCT00628394
Eligibility Criteria:
Inclusion Criteria:
* DSM-IV diagnosis of schizophrenia or schizoaffective disorder.
* Males and females.
* Ages 18-60 years old.
* All races and ethnicities.
Exclusion Criteria:
* Diagnosis of an organic brain disease.
* Diagnosis of DSM-IV alcohol or substance abuse within the last month or DSM-IV alcohol or substance dependence within the last 3 months.
* Meet criteria for primary negative symptoms, established by clinical judgment.
* Current or past history of clozapine treatment for antipsychotic non-response.
* Patients hospitalized in a psychiatric hospital within the previous 30 days.
* Patients with an unstable medical condition, as determined by the Investigator
* Colorblindness
* Concurrent treatment with electroconvulsive therapy or psychotherapy.
* Pregnant women.
* Must be able to read, speak, and understand English.
* We do not have the resources necessary to properly study non-English speaking patients in this study. The computer software used for cognitive remediation and some clinical assessments are only available in English. The need to provide such resources in foreign languages would be prohibitive to the successful completion of the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00628394
Study Brief:
Protocol Section:
NCT00628394